Riociguat for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Real-life data from the EXPERT registry
Michael Halank (Dresden, Germany), Michael Halank, Marc Humbert, Miguel-Angel Gomez Sanchez, David Pittrow, Marius Hoeper, Ekkehard Grünig, H. Ardeschir Ghofrani, Hubert Wirtz, Hans Klose, Ralf Ewert, Tobias J. Lange, Jens Klotsche, Christian Meier, Monika Brunn, Gerald Simonneau
Source: International Congress 2015 – Pulmonary hypertension: new treatment insights
Session: Pulmonary hypertension: new treatment insights
Session type: Oral Presentation
Number: 4999
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Michael Halank (Dresden, Germany), Michael Halank, Marc Humbert, Miguel-Angel Gomez Sanchez, David Pittrow, Marius Hoeper, Ekkehard Grünig, H. Ardeschir Ghofrani, Hubert Wirtz, Hans Klose, Ralf Ewert, Tobias J. Lange, Jens Klotsche, Christian Meier, Monika Brunn, Gerald Simonneau. Riociguat for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Real-life data from the EXPERT registry. Eur Respir J 2015; 46: Suppl. 59, 4999
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: